Millipore Sigma Vibrant Logo

341205 Etoposide - CAS 33419-42-0 - Calbiochem

Etoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity.

Etoposide - CAS 33419-42-0 - Calbiochem: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: VP-16

Primary Target: topoisomerase 2
View Products on Sigmaaldrich.com
341205
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
33419-42-0C₂₉H₃₂O₁₃

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
341205-25MG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Kst.-Ampulle 25 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewA cell-permeable derivative of podophyllotoxin that acts as a topoisomerase II inhibitor (IC50 = 59.2 µM) has major activity against a number of tumors, including germ cell neoplasms, small cell lung cancer, and malignant lymphoma. Induces apoptosis in mouse thymocytes and in HL-60 human leukemia cells.
      Catalogue Number341205
      Brand Family Calbiochem®
      SynonymsVP-16
      References
      ReferencesDe Lange, A.M., et al. 1995. J. Virol. 69, 2082.
      Kaufman, S.H., et al. 1993. Cancer Res. 53, 3976.
      Onishi, Y., et al. 1993. Biochim. Biophys. Acta 1175, 147.
      Terada, T., et al. 1993. J. Med. Chem. 36, 1689.
      Wazniak, A.J., et al. 1991. J. Clin. Oncol. 9, 70.
      Einhorn, L.H., et al. 1988. J. Clin. Oncol. 6, 451.
      Issel, B.F. 1982. Cancer Chemother. Pharmacol. 7, 73.
      Product Information
      CAS number33419-42-0
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₂₉H₃₂O₁₃
      Chemical formulaC₂₉H₃₂O₁₃
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationEtoposide, CAS 33419-42-0, is cell-permeable inhibitor of topoisomerase II inhibitor (IC50 = 59.2 µM). Displays anti-tumor activity.
      Biological Information
      Primary Targettopoisomerase 2
      Primary Target IC<sub>50</sub>59.2 µM inhibiting topoisomerase II
      Purity>95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSKC0190000
      Safety Information
      R PhraseR: 22-45

      Harmful if swallowed.
      May cause cancer.
      S PhraseS: 26-36/37/39-45-53

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing, gloves and eye/face protection.
      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Avoid exposure - obtain special instructions before use.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful & Carcinogenic / Teratogenic
      Storage +15°C to +30°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      341205-25MG 04055977215434

      Documentation

      Etoposide - CAS 33419-42-0 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Etoposide - CAS 33419-42-0 - Calbiochem Analysenzertifikate

      TitelChargennummer
      341205

      Literatur

      Übersicht
      De Lange, A.M., et al. 1995. J. Virol. 69, 2082.
      Kaufman, S.H., et al. 1993. Cancer Res. 53, 3976.
      Onishi, Y., et al. 1993. Biochim. Biophys. Acta 1175, 147.
      Terada, T., et al. 1993. J. Med. Chem. 36, 1689.
      Wazniak, A.J., et al. 1991. J. Clin. Oncol. 9, 70.
      Einhorn, L.H., et al. 1988. J. Clin. Oncol. 6, 451.
      Issel, B.F. 1982. Cancer Chemother. Pharmacol. 7, 73.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision30-October-2023 JSW
      SynonymsVP-16
      DescriptionA cell-permeable, topoisomerase II inhibitor (IC50 = 59.2 µM). A derivative of podophyllotoxin (Cat. No. 540040) that has major activity against a number of tumors, including germ cell neoplasms, small cell lung cancer, and malignant lymphoma. Induces apoptosis in mouse thymocytes and in HL-60 human leukemia cells.
      FormWhite solid
      CAS number33419-42-0
      RTECSKC0190000
      Chemical formulaC₂₉H₃₂O₁₃
      Structure formulaStructure formula
      Purity>95% by HPLC
      SolubilityDMSO (25 mg/ml)
      Storage Protect from light
      +15°C to +30°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful & Carcinogenic / Teratogenic
      Merck USA index14, 3886
      ReferencesDe Lange, A.M., et al. 1995. J. Virol. 69, 2082.
      Kaufman, S.H., et al. 1993. Cancer Res. 53, 3976.
      Onishi, Y., et al. 1993. Biochim. Biophys. Acta 1175, 147.
      Terada, T., et al. 1993. J. Med. Chem. 36, 1689.
      Wazniak, A.J., et al. 1991. J. Clin. Oncol. 9, 70.
      Einhorn, L.H., et al. 1988. J. Clin. Oncol. 6, 451.
      Issel, B.F. 1982. Cancer Chemother. Pharmacol. 7, 73.